The DOI matches its Crossref record; 227 of the 229 references it cites were found in a registry or an index.
Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment
Open accessAbstract
Obsessive compulsive disorder is prevalent, disabling, incompletely understood, and often resistant to current therapies. Established treatments consist of specialized cognitive-behavioral psychotherapy and pharmacotherapy with medications targeting serotonergic and dopaminergic neurotransmission. However, remission is rare, and more than a quarter of OCD sufferers receive little or no benefit from these approaches, even when they are optimally delivered. New insights into the disorder, and new treatment strategies, are urgently needed. Recent evidence suggests that the ubiquitous excitatory neurotransmitter glutamate is dysregulated in OCD, and that this dysregulation may contribute to the pathophysiology of the disorder. Here we review the current state of this evidence, including neuroimaging studies, genetics, neurochemical investigations, and insights from animal models. Finally, we review recent findings from small clinical trials of glutamate-modulating medications in treatment-refractory OCD. The precise role of glutamate dysregulation in OCD remains unclear, and we lack blinded, well-controlled studies demonstrating therapeutic benefit from glutamate-modulating agents. Nevertheless, the evidence supporting some important perturbation of glutamate in the disorder is increasingly strong. This new perspective on the pathophysiology of OCD, which complements the older focus on monoaminergic neurotransmission, constitutes an important focus of current research and a promising area for the ongoing development of new therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“structural abnormalities in CSTC circuits involving orbitofrontal cortex (OFC), anterior cingulate cortex (ACC), and striatum have been repeatedly demonstrated in OCD 51–53.”
From DISSECTING OCD CIRCUITS: FROM ANIMAL MODELS TO TARGETED TREATMENTS: Review: Dissecting OCD Circuits: Animals to Treatments (2015) · cites this paper as [51]
In the citing paper
“The role of this glutamate transporter gene in OCD is also supported by the observation that the anti-glutamatergic drug riluzole can be beneficial in the treatment of OCD and by the finding of elevated glutamate levels in the CSF of OCD patients (Pittenger et al. 2011).”
From The neurobiological link between OCD and ADHD (2014) · cites this paper as Pittenger et al. 2011
In the citing paper
“Studies using neurochemical and neuroimaging methods have shown that various neurotransmitters are implicated in the pathophysiology of this disorder, including serotonin [1], dopamine [2] and glutamate [3].”
From P300 and delay-discounting in obsessive–compulsive disorder (2022) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Oxford University Press eBooks · doi:10.1037/10518-009 · Cited by 19,766
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
The Synaptic Organization of the Brain
(2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195159561.001.1 · Cited by 3,574
The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication
Ruscio, A. M., Stein, D. J., Chiu, W. T., & Kessler, R. C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.94 · Cited by 2,771
Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites
Robins, L. N. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210031005 · Cited by 2,550
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534
Flagged first, then by citations
2 of the 229 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Neuroinflammation and psychiatric illness
Najjar, S., Pearlman, D. M., Alper, K., Najjar, A., & Devinsky, O. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-43 · Cited by 733
Revealing the complex genetic architecture of obsessive–compulsive disorder using meta-analysis
International Obsessive Compulsive Disorder Foundation Genetics Collaborative (IOCDF-GC) and OCD Collaborative Genetics Association Studies (OCGAS) (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.154 · Cited by 618
Repeated cortico-striatal stimulation generates persistent OCD-like behavior
Ahmari, S. E., Spellman, T., Douglass, N. L., Kheirbek, M. A., Simpson, H. B., Deisseroth, K., Gordon, J. A., & Hen, R. (2013) · Science · doi:10.1126/science.1234733 · Cited by 502
Genome-wide association study of obsessive-compulsive disorder
Stewart, S. E., Yu, D., Scharf, J. M., Neale, B. M., Fagerness, J. A., Mathews, C. A., Arnold, P. D., Evans, P. D., Gamazon, E. R., Osiecki, L., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.85 · Cited by 384
Self-citationRandomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
Rodriguez, C. I., Kegeles, L. S., Levinson, A., Feng, T., Marcus, S. M., Vermes, D., Flood, P., & Simpson, H. B. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.150 · Cited by 386
Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS
Mattheisen, M., Samuels, J. F., Wang, Y., Greenberg, B. D., Fyer, A. J., McCracken, J. T., Geller, D. A., Murphy, D. L., Knowles, J. A., Grados, M. A., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.43 · Cited by 321
Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder
Goodman, W. K., Storch, E. A., & Sheth, S. A. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20111601 · Cited by 281
Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer’s Disease
Sharma, C., Kim, S., Nam, Y., Jung, U. J., & Kim, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094850 · Cited by 253
Tinnitus and anxiety disorders: a review
Pattyn, T., Van Den Eede, F., Vanneste, S., Cassiers, L., Veltman, D. J., Van De Heyning, P., & Sabbe, B. C. G. (2016) · Hearing Research · doi:10.1016/j.heares.2015.08.014 · Cited by 233
Pharmacological Treatment of Obsessive-Compulsive Disorder
Pittenger, C., & Bloch, M. H. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.05.006 · Cited by 222
Self-citationInflammation in the Neurocircuitry of Obsessive-Compulsive Disorder
Attwells, S., Setiawan, E., Wilson, A. A., Rusjan, P., Mizrahi, R., Miler, L., Xu, C., Richter, M. A., Kahn, A., Kish, S. J., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.1567 · Cited by 213
Goodman, W. K., Grice, D. E., Lapidus, K. A. B., & Coffey, B. J. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.06.004 · Cited by 221
Cerebral cortex : principles of operation
Rolls, E. T. (2016) · doi:10.82444/warw.33712699 · Cited by 187
Striatopallidal dysfunction underlies repetitive behavior in Shank3-deficient model of autism
Wang, W., Li, C., Chen, Q., van der Goes, M.-S. H., Hawrot, J., Yao, A. Y., Gao, X., Lu, C., Zang, Y., Zhang, Q., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87997 · Cited by 181
N-Acetylcysteine in the Treatment of Excoriation Disorder: A Randomized Clinical Trial
Grant, J. E., Chamberlain, S. R., Redden, S. A., Leppink, E. W., Odlaug, B. L., & Kim, S. W. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0060 · Cited by 172
Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder
Bloch, M. H., Wasylink, S., Landeros-Weisenberger, A., Panza, K. E., Billingslea, E., Leckman, J. F., Krystal, J. H., Bhagwagar, Z., Sanacora, G., & Pittenger, C. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.028 · Cited by 162
Self-citationFineberg, N. A., Hollander, E., Pallanti, S., Walitza, S., Grünblatt, E., Dell’Osso, B. M., Albert, U., Geller, D. A., Brakoulias, V., Janardhan Reddy, Y. C., et al. (2020) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000314 · Cited by 161
Compulsivity in anorexia nervosa: a transdiagnostic concept
Godier-McBard, L. R., & Park, R. J. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.00778 · Cited by 157
Naaijen, J., Bralten, J., Poelmans, G., The IMAGE consortium, Faraone, S., Asherson, P., Banaschewski, T., Buitelaar, J., Franke, B., P Ebstein, R., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.273 · Cited by 142
A Critical Review of Magnetic Resonance Spectroscopy Studies of Obsessive-Compulsive Disorder
Brennan, B. P., Rauch, S. L., Jensen, J. E., & Pope, H. G. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.023 · Cited by 148
Simpson, H. B., Shungu, D. C., Bender, J., Mao, X., Xu, X., Slifstein, M., & Kegeles, L. S. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.132 · Cited by 138
Glutamatergic synapses in neurodevelopmental disorders
Moretto, E., Murru, L., Martano, G., Sassone, J., & Passafaro, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.014 · Cited by 146
Ahmari, S. E., & Dougherty, D. D. (2015) · Depression and Anxiety · doi:10.1002/da.22367 · Cited by 128
Endres, D., Pollak, T. A., Bechter, K., Denzel, D., Pitsch, K., Nickel, K., Runge, K., Pankratz, B., Klatzmann, D., Tamouza, R., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-021-01700-4 · Cited by 133
Naaijen, J., Lythgoe, D. J., Amiri, H., Buitelaar, J. K., & Glennon, J. C. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.02.009 · Cited by 117
The neurobiological link between OCD and ADHD
Brem, S., Grünblatt, E., Drechsler, R., Riederer, P., & Walitza, S. (2014) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-014-0146-x · Cited by 109
Microglial Dysregulation in OCD, Tourette Syndrome, and PANDAS
Frick, L. R., & Pittenger, C. (2016) · Journal of Immunology Research · doi:10.1155/2016/8606057 · Cited by 114
Self-citationPaydary, K., Akamaloo, A., Ahmadipour, A., Pishgar, F., Emamzadehfard, S., & Akhondzadeh, S. (2016) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12370 · Cited by 106
Al-Otaish, H., AL-Ayadhi, L. Y., Bjørklund, G., Chirumbolo, S., Urbina, M. A., & El-Ansary, A. K. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0186-6 · Cited by 109
Tang, R., Noh, H. J., Wang, D., Sigurðsson, S., Swofford, R., Perloski, M., Duxbury, M. M., Patterson, E. E., Albright, J., Castelhano, M. G., et al. (2014) · Genome biology · doi:10.1186/gb-2014-15-3-r25 · Cited by 107
Stewart, S. E., Mayerfeld, C., Arnold, P. D., Crane, J. R., O'Dushlaine, C., Fagerness, J. A., Yu, D., Scharf, J. M., Chan, E., Kassam, F., et al. (2013) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32137 · Cited by 102
Xu, J., Liu, R.-J., Fahey, S., Frick, L. R., Leckman, J. F., Vaccarino, F. M., Duman, R. S., Williams, K. B., Swedo, S. E., & Pittenger, C. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.19070698 · Cited by 102
Self-citationOliver, G., Dean, O., Camfield, D., Blair-West, S., Ng, C., Berk, M., & Sarris, J. (2015) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2015.13.1.12 · Cited by 96
Fonseka, T. M., Richter, M. A., & Müller, D. J. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0510-8 · Cited by 93
Treatment-resistant OCD: Pharmacotherapies in adults
van Roessel, P., Grassi, G., Aboujaoude, E. N., Menchón, J. M., Ameringen, M. V., & Rodríguez, C. I. (2022) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2022.152352 · Cited by 103
Zike, I. D., Xu, T., Hong, N., & Veenstra-VanderWeele, J. M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.09.012 · Cited by 83
Zhang, X., Peng, S., Shen, L.-P., Zhuang, Q., Li, B., Xie, S.-T., Li, Q.-X., Shi, M.-R., Ma, T.-Y., Zhang, Q., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008456117 · Cited by 85
Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder
Marinova, Z., Chuang, D.-M., & Fineberg, N. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170320104237 · Cited by 83
Sarris, J. J., Oliver, G., Camfield, D., Dean, O. M., Dowling, N. L., Smith, D. J., Murphy, J., Menon, R., Berk, M., Blair‐West, S., et al. (2015) · CNS Drugs · doi:10.1007/s40263-015-0272-9 · Cited by 85
Hungry for reward: How can neuroscience inform the development of treatment for Anorexia Nervosa?
Park, R. J., Godier-McBard, L. R., & Cowdrey, F. A. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.07.007 · Cited by 88
Obsessive compulsive disorder and the glutamatergic system
Kariuki, C. M., Gomez‐Mancilla, B., & Stein, D. J. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000017 · Cited by 82
Obsessive-compulsive disorder: Insights from animal models
Szechtman, H., Ahmari, S. E., Beninger, R. J., Eilam, D., Harvey, B. H., Edemann-Callesen, H., & Winter, C. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.019 · Cited by 90
Pittenger, C., Bloch, M. H., Wasylink, S., Billingslea, E., Simpson, R., Jakubovski, E., Kelmendi, B., Sanacora, G., & Coric, V. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09123 · Cited by 80
Pearlman, D. M., Vora, H. S., Marquis, B. G., Najjar, S., & Dudley, L. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.137018 · Cited by 81
Learning From Animal Models of Obsessive-Compulsive Disorder
Monteiro, P., & Feng, G. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.020 · Cited by 80
Bokor, G., & Anderson, P. D. (2014) · Journal of Pharmacy Practice · doi:10.1177/0897190014521996 · Cited by 79
Augmentation strategies in obsessive–compulsive disorder
Arumugham, S. S., & Reddy, J. Y. C. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.160 · Cited by 78
Xu, J., Jakher, Y., & Ahrens‐Nicklas, R. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207490 · Cited by 74
Investigating the Role of Glutamate in Obsessive-Compulsive Disorder: Current Perspectives
Karthik, S., Sharma, L. P., & Narayanaswamy, J. C. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s211703 · Cited by 78
Hashemiyoon, R., Kuhn, J., & Visser-Vandewalle, V. E. R. M. (2016) · Brain Topography · doi:10.1007/s10548-016-0525-z · Cited by 75
Using mice to model Obsessive Compulsive Disorder: From genes to circuits
Ahmari, S. E. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.009 · Cited by 71
Sex differences in the genetic architecture of obsessive–compulsive disorder
Khramtsova, E. A., Ramalho, R. S. C., Derks, E. M., Yu, D., Workgroup, T. P. G. D., Davis, L. K., & Stranger, B. E. (2018) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32687 · Cited by 71
Esalatmanesh, S., Abrishami, Z., Zeinoddini, A., Rahiminejad, F., Sadeghi, M., Najarzadegan, M., Shalbafan, M., & Akhondzadeh, S. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12430 · Cited by 65
The Cambridge Handbook of Substance and Behavioral Addictions
Sussman, S. Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591 · Cited by 64
Fronto-Striatal Glutamate in Autism Spectrum Disorder and Obsessive Compulsive Disorder
Naaijen, J., Zwiers, M. P., Amiri, H., Williams, S., Durston, S., Oranje, B., Brandeis, D., Boecker-Schlier, R., Ruf, M., Wolf, I., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.260 · Cited by 66
Piras, F., Piras, F., Abe, Y., Agarwal, S. M., Anticevic, A., Ameis, S. H., Arnold, P. D., Banaj, N., Bargalló, N., Batistuzzo, M. C., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01276-z · Cited by 67
Self-citationGlutamatergic agents for OCD and related disorders
Pittenger, C. (2015) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-015-0051-8 · Cited by 62
Self-citationN-Acetylcysteine for Pediatric Obsessive-Compulsive Disorder: A Small Pilot Study
Li, F., Welling, M. C., Johnson, J. A., Coughlin, C. G., Mulqueen, J., Jakubovski, E., Coury, S. M., Landeros‐Weisenberger, A., & Bloch, M. H. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2019.0041 · Cited by 61
Self-citationRodríguez, C. I., Kegeles, L. S., Levinson, A. R., Ogden, R. T., Mao, X., Milak, M. S., Vermes, D., Xie, S., Hunter, L. E., Flood, P. D., et al. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2015.06.001 · Cited by 61
van de Vondervoort, I. I. G. M., Poelmans, G., Aschrafi, A., Pauls, D. L., Buitelaar, J. K., Glennon, J. C., & Franke, B. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140327 · Cited by 58
Perinatal Obsessive–Compulsive Disorder: Epidemiology, Phenomenology, Etiology, and Treatment
Hudepohl, N. S., MacLean, J. V., & Osborne, L. M. (2022) · Current Psychiatry Reports · doi:10.1007/s11920-022-01333-4 · Cited by 76
Abe, Y., Sakai, Y., Nishida, S., Nakamae, T., Yamada, K., Fukui, K., & Narumoto, J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.08.017 · Cited by 56
Banov, M. D., Young, J. R., Dunn, T., & Szabo, S. T. (2019) · CNS Spectrums · doi:10.1017/s1092852919001238 · Cited by 62
Pittenger, C., Adams, T. G., Gallezot, J., Crowley, M. J., Nabulsi, N., Ropchan, J., Gao, H., Kichuk, S. A., Simpson, R., Billingslea, E., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.021 · Cited by 55
Self-citationBrennan, B. P., Tkachenko, O. N., Schwab, Z. J., Juelich, R. J., Ryan, E., Athey, A. J., Pope, H. G., Jenike, M. A., Baker, J. T., Killgore, W. D. S., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.36 · Cited by 58
Brain circuitry of compulsivity and impulsivity
Grant, J. E., & Kim, S. W. (2013) · CNS Spectrums · doi:10.1017/s109285291300028x · Cited by 61
Skin-Picking Disorder: A Guide to Diagnosis and Management
Jafferany, M., & Patel, A. (2019) · CNS Drugs · doi:10.1007/s40263-019-00621-7 · Cited by 57
van den Boom, B. J. G., Mooij, A. H., Misevičiūtė, I., Denys, D., & Willuhn, I. (2019) · Genes, Brain and Behavior · doi:10.1111/gbb.12557 · Cited by 55
Genetics of obsessive-compulsive disorder
Viswanath, B., Purty, A., Nestadt, G., & Samuels, J. (2019) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_518_18 · Cited by 58
Zhu, D., Yuan, T., Gao, J., Xu, Q., Xue, K., Zhu, W., Tang, J., Liu, F., Wang, J., & Yu, C. (2021) · Human Brain Mapping · doi:10.1002/hbm.25362 · Cited by 54
Does compulsive behavior in Anorexia Nervosa resemble an addiction? A qualitative investigation
Godier-McBard, L. R., & Park, R. J. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.01608 · Cited by 52
O’Neill, J., Piacentini, J. C., Chang, S. W., Ly, R., Lai, T. M., Armstrong, C. C., Bergman, L., Rozenman, M. S., Peris, T. S., Vreeland, A., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.77 · Cited by 54
Lustberg, D. J., Iannitelli, A. F., Tillage, R. P., Pruitt, M., Liles, L. C., & Weinshenker, D. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05512-0 · Cited by 51
Gender-specific approach in psychiatric diseases: Because sex matters
Franceschini, A., & Fattore, L. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173895 · Cited by 56
Cefdinir for Recent-Onset Pediatric Neuropsychiatric Disorders: A Pilot Randomized Trial
Murphy, T. K., Parker-Athill, E. C., Lewin, A. B., Storch, E. A., & Mutch, P. J. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0010 · Cited by 52
Price, J. B., Rusheen, A. E., Barath, A. S., Cabrera, J. M. R., Shin, H., Chang, S.-Y., Kimble, C. J., Bennet, K. E., Blaha, C. D., Lee, K. H., et al. (2020) · Neurosurgical FOCUS · doi:10.3171/2020.4.focus20167 · Cited by 54
Heidari, M., Zarei, M., Hosseini, S. M. R., Taghvaei, R., Maleki, H., Tabrizi, M., Fallah, J., & Akhondzadeh, S. (2014) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000043 · Cited by 48
Reed, D. D., Naudé, G. P., Gelino, B. W., & Amlung, M. T. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.011 · Cited by 48
Pharmacotherapeutic Strategies and New Targets in OCD
Pittenger, C. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_204 · Cited by 54
Self-citationZhu, Y., Fan, Q., Xu, H., Zhang, H., Chen, J., Wang, Z., Zhang, Z., Tan, L., Xiao, Z., Tong, S., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.008 · Cited by 52
Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach
Grados, M. A., Specht, M. W., Sung, H.-M., & Fortune, D. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.845553 · Cited by 49
Karpinski, M., Mattina, G. F., & Steiner, M. S. (2016) · Neuroendocrinology · doi:10.1159/000453664 · Cited by 49
Lamothe, H., Schreiweis, C., Mondragón-González, S. L., Rebbah, S., Lavielle, O., Mallet, L., & Burguière, E. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02323-7 · Cited by 51
Gassó, P., Ortiz, A. E., Mas, S., Morer, Á., Calvo, A., Bargalló, N., Lafuente, A., & Lázaro, L. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.07.035 · Cited by 51
The Prevention and Treatment of Gambling Disorders: Some Art, Some Science
Derevensky, J. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.024 · Cited by 45
Considering the Overlap and Nonoverlap of Compulsivity, Impulsivity, and Addiction
Blum, A. W., & Grant, J. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.038 · Cited by 44
Neurobiological Foundations of Behavioral Addictions
Vaccaro, A. G., & Potenza, M. N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.016 · Cited by 45
Neurobiology of Substance Addictions
Christie, N. C., & Bechara, A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.015 · Cited by 44
Sensitization of Incentive Salience and the Transition to Addiction
Warlow, S. M., Baumgartner, H. M., Freeland, C. M., Naffziger, E. E., Olney, J. J., Berridge, K. C., & Robinson, M. J. F. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.006 · Cited by 46
Naaijen, J., Forde, N. J., Lythgoe, D. J., Akkermans, S. E. A., Openneer, T. J. C., Dietrich, A., Zwiers, M. P., Hoekstra, P. J., & Buitelaar, J. K. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.11.013 · Cited by 45
Mindfulness-Based Interventions Applied to Addiction Treatments
Kechter, A., & Black, D. S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.040 · Cited by 43
Multiple Memory Systems, Addiction, and Health Habits: New Routes for Translational Science
Stacy, A. W., Pike, J. R., & Lee, A. Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.017 · Cited by 43
Tanning as an Addiction: The State of the Research and Implications for Intervention
Miller, K. A., & Mays, D. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.037 · Cited by 43
Schulte, E. M., Schiestl, E. T., & Gearhardt, A. N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.035 · Cited by 43
Double-Blind Placebo-Controlled Study of Memantine in Trichotillomania and Skin-Picking Disorder
Grant, J. E., Chesivoir, E. K., Valle, S., Ehsan, D. A., & Chamberlain, S. R. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20220737 · Cited by 50
Şimşek, Ş., Yüksel, T., Çim, A., & Kaya, S. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw027 · Cited by 44
Behavioral Economics and Addictive Disorders
Jarmolowicz, D. P., & Schneider, T. D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.005 · Cited by 42
Prevention and Treatment of Compulsive Buying Disorder
Galimov, A., & Black, D. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.027 · Cited by 42
Blum, K., Roy, A. K., Podesta, A., Modestino, E. J., Steinberg, B., Gondré-Lewis, M. C., Baron, D. A., Thanos, P. K., Lott, L., Badgaiyan, S., et al. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.031 · Cited by 42
Prevention and Treatment of “Food Addiction”
Davis, C., & Mason, A. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.023 · Cited by 42
Metadata
- Authors
- Pittenger, C., Bloch, M. H., & Williams, K.
- Affiliations
- Yale University (US)
- Corresponding author
- Pittenger, Christopher
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 132
- Issue
- 3
- Pages
- 314-332
- ISSN
- 0163-7258 (ISSN-L)
- PMC
- PMC3205262
- OpenAlex
- W2109125813
- Cited by
- 426
- References
- 229
- Citations by year
- 2026: 30 · 2025: 24 · 2024: 23 · 2023: 31 · 2022: 17 · 2021: 33 · 2020: 65 · 2019: 28 · 2018: 25 · 2017: 26 · 2016: 39 · 2015: 34 · 2014: 25 · 2013: 18 · 2012: 7
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (R34MH083115, K08MH081190, K23MH091240, R25MH077823)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- obsessive-compulsive disorder, glutamate, glutamate dysregulation, treatment-refractory OCD, pathophysiology, excitatory neurotransmission, neuroimaging, animal models, cognitive behavioral therapy, pharmacotherapy
- MeSH terms
- Animals, Clinical Trials as Topic, Drug Evaluation, Preclinical, Humans, Neurobiology, Obsessive-Compulsive Disorder, Randomized Controlled Trials as Topic, Neurotransmitter Agents, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
